文献速递白血病

急性髓系白血病中染色体碎裂综合征常与高度复杂核型、广泛克隆异质性及治疗难治性相关

Chromoanagenesis Is Frequently Associated With Highly Complex Karyotypes, Extensive Clonal Heterogeneity, and Treatment Refractoriness in Acute Myeloid Leukemia.
PubMed 文献 · Am J Hematol · 2025-01-27

研究采用光学基因组图谱对410例急性髓系白血病(AML)患者(292例初诊、118例难治/复发)检测染色体碎裂综合征(CAG),65例(16%)检出CAG。CAG患者高度复杂核型、单体核型、广泛克隆异质性、基因扩增及TP53缺失/突变频率均显著高于无CAG者(p<0.0001)。初诊AML中CAG患者总生存短于无CAG者(中位5 vs 14个月,p<0.0001),但多因素分析中CAG似非独立生存危险因素。

要点

  • 410例AML中65例(16%)经光学基因组图谱检出CAG。
  • CAG者高度复杂核型92% vs 11%、单体核型88% vs 12%(p<0.0001)。
  • 初诊AML中CAG者中位总生存5 vs 14个月(p<0.0001),多因素分析非独立危险因素。

核心结论

  • CAG在AML中常与高危染色体改变和基因组不稳定相关,可能促成本组患者的治疗难治性和较差生存。

研究设计与样本

  • 研究采用光学基因组图谱对410例确诊AML患者进行CAG检测,其中初诊292例、难治/复发118例。
  • CAG定义为在一个或多个染色体区域内存在结构异常和/或节段性拷贝数改变的簇(含10个或以上断裂点)。

主要发现

  • 65例(16%)患者检出CAG。
  • CAG患者较无CAG者高度复杂核型频率更高(92% vs 11%,p<0.0001)。
  • CAG患者较无CAG者单体核型频率更高(88% vs 12%,p<0.0001)。
  • CAG患者较无CAG者广泛克隆异质性频率更高(75% vs 7%,p<0.0001)。
  • CAG患者较无CAG者基因扩增频率更高(49% vs 1%,p<0.0001),TP53缺失/突变频率更高(92% vs 9%,p<0.0001)。

关键数值与推荐

  • 在具有上述高危细胞遗传学异常/核型的AML患者中,约三分之二检出CAG。
  • 42例初诊AML伴CAG患者中36例接受治疗和随访,其中28例(78%)无反应或仅部分缓解。
  • 初诊AML中CAG患者中位总生存5个月 vs 无CAG者14个月(p<0.0001)。
  • 多因素分析中CAG似非生存的独立危险因素。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chromoanagenesis (CAG) encompasses a spectrum of catastrophic genomic events, including chromothripsis, chromoanasynthesis, and chromoplexy. We studied CAG in 410 patients with a diagnosis of acute myeloid leukemia (AML), 292 newly diagnosed (ND), and 118 refractory/relapsed, using optical genome mapping. CAG was identified by the presence of clusters (with 10 or more breakpoints) of structural abnormalities and/or segmental copy number alterations within one or more chromosomal regions. CAG was detected in 65 (16%) patients. Compared with patients without CAG, those with CAG showed significantly (p < 0.0001) higher frequencies of highly complex karyotype (92% vs. 11%), monosomal karyotype (88% vs. 12%), extensive clonal heterogeneity (75% vs. 7%), gene amplification (49% vs. 1%), and TP53 deletion/mutation (92% vs. 9%). Overall, CAG was detected in about two-thirds of AML patients who exhibited the abovementioned high-risk cytogenetic abnormalities/karyotype. Among the 42 patients with ND AML and CAG, 36 received treatments and follow-ups, and 28 (78%) had no or only partial response to therapy. Among patients with ND AML, those with CAG had a shorter overall survival than those without CAG (median survival: 5 vs. 14 months, p < 0.0001). However, in multivariate analysis, CAG did not appear to be an independent risk factor for survival. These results indicate that CAG is frequently associated with high-risk chromosomal alterations and genomic instability in AML and may contribute to treatment refractoriness and inferior survival in this subset of AML patients.

来源:Am J Hematol,查看原文。版权归原作者所有。

引用

  1. Wei Q, Hu S, Loghavi S, et al. Chromoanagenesis Is Frequently Associated With Highly Complex Karyotypes, Extensive Clonal Heterogeneity, and Treatment Refractoriness in Acute Myeloid Leukemia. Am J Hematol. 2025. PMID: 39871121. doi:10.1002/ajh.27575

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。